The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
By Matthew J. Page, J. McKenzie, Patrick M. M. Bossuyt, I. Boutron, Tammy Hoffmann, C. Mulrow, Larissa Shamseer, J. Tetzlaff, Elie A. Akl, S. Brennan and 16 more. PLoS Medicine, 2021
25,061 citations recorded by the source corpus.
Matthew Page and co-authors describe PRISMA 2020, an updated reporting guideline for systematic reviews and meta-analyses.
Subfields: General Health Professions, Sociology and Political Science, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/ab47afbba9c1f7dc2f02b7ce0182a4d2a78238ee
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
Citations in the corpus
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024, neutral): “39 Guidelines about systematic reviews and bias assessment are provided in appendix 1 (section 2.1.3), with risk factor-specific information—including details about data sources, systematic reviews, data extraction, and modelling strategies—provided in appendix 1 (section 6) and in the Methods Web…”
- Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic (2021, neutral): “Because only three studies used diagnostic instruments to measure prevalence, we did not have sufficient data to explore the effect of a bias covariate on data from screening scales identifying probable cases of depressive or anxiety disorders (appendix pp 8–9).”
- Effects of aromatherapy on sleep quality in patients: Protocol for an umbrella review (2025, positive): “All stages of the selection process will adhere to the guidelines presented in the PRISMA flow chart [17].”
- Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI (2022, neutral): “Although familiarity with DECIDE-AI might be useful to inform some aspects of the design and conduct of studies within the guideline’s scope 28 , adherence to the guideline alone should not be interpreted as an indication of methodological quality (which is the realm of methodological guidelines…”
- Computation (2020, neutral): “The intervals of the criteria are divided into s grey classes, and then their center-points λ 1 , λ 2 , . . . , λ S are determined from the standard data.”
- Pediatric resting EEG collection, preprocessing, and analysis: A systematic review (2026, unknown): “The EQUATOR Network has also published several checklists for various aspects of health research, including the Consolidated Standards of Reporting Trials (CONSORT; Hopewell et al., 2025) and the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA; Page et al., 2021).”
- Aperiodic and Hurst EEG exponents across early human brain development: A systematic review (2024, unknown): “The systematic review was completed according to the PRISMA guidelines (Page et al., 2021) and pre-registered with the international Prospective Register of Systematic Reviews (PROSPERO Registration number: CRD42023363294).”